Ixchiq lyophilized antigen component, live, for injection Images
Generic Name: chikungunya vaccine, live (cvx 317)
This medication has been identified as Ixchiq lyophilized antigen component, live, for injection. It is supplied by Valneva USA Inc.
Ixchiq is used in the treatment of Chikungunya Disease Prevention and belongs to the drug class viral vaccines. Ixchiq lyophilized antigen component, live, for injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Ixchiq
- Generic Name
- chikungunya vaccine, live (cvx 317)
- Strength
- lyophilized antigen component, live, for injection
- Availability
- Prescription only
- Drug Class
- Viral vaccines
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Valneva USA Inc.
- National Drug Code (NDC)
- 42515-0003
See also:
More about Ixchiq (chikungunya vaccine, live (cvx 317))
- Check interactions
- Compare alternatives
- Drug images
- Latest FDA alerts (1)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: viral vaccines
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.